Healthcare Triangle's Subsidiary Launches ZILOY: A GenAI-Powered Integrative Mental Health Platform for Hybrid and Online Care Models with ROI Focus.

Monday, Aug 4, 2025 9:20 am ET2min read

Healthcare Triangle's subsidiary, QuantumNexis, launches ZILOY, a GenAI-powered integrative mental health platform in the US. ZILOY offers hybrid and online care models, combining evidence-based clinical science with holistic practices. The platform aims to bridge gaps in the fragmented behavioral health ecosystem and provide personalized wellness journeys for individuals and families. ZILOY is designed to scale and deliver ROI for enterprises.

Healthcare Triangle, Inc. (Nasdaq: HCTI), a leader in digital transformation solutions for the healthcare and life sciences industries, has announced the U.S. launch of ZILOY, a GenAI-powered integrative mental health platform developed by its wholly owned subsidiary, QuantumNexis. This platform offers hybrid and online care models, combining evidence-based clinical science with holistic practices to address the growing demand for mental health services.

ZILOY aims to bridge critical gaps in the fragmented behavioral health ecosystem by providing personalized wellness journeys that unite modern psychiatry, clinical psychology, therapeutic yoga, and clinical nutrition, all powered by artificial intelligence and led by licensed clinicians. The platform is designed to meet the mental health needs of individuals and families across all life stages, from childhood through senior care.

The U.S. launch of ZILOY comes at a time when mental health demand is surging. According to the National Institute of Mental Health, over 60 million adults experienced a mental illness in the past year, yet fewer than half received treatment. Anxiety disorders alone impact 42 million Americans, and one in four adults is diagnosed annually. The current system faces bottlenecks such as long wait times, high costs, and inconsistent access, highlighting the urgent need for scalable, tech-enabled solutions.

ZILOY addresses these gaps by offering a GenAI-powered platform built for clinical impact, digital scale, and enterprise ROI. The platform begins with a comprehensive digital self-assessment, evaluating emotional, psychological, and lifestyle factors. A multidisciplinary clinical team develops a dynamic, personalized care plan that evolves with each user's needs and progress. Whether addressing behavioral challenges in children, managing adult stress and burnout, or supporting cognitive health in seniors, ZILOY offers a unified care model that is clinically robust, culturally intelligent, and accessible from anywhere.

The platform is secure, scalable, and clinically trusted, with HIPAA-compliant architecture, end-to-end encryption, multi-factor authentication, and secure cloud hosting. It merges advanced GenAI capabilities with enterprise-grade security protocols and clinical governance, ensuring clinical integrity and digital safety for every session, assessment, and engagement.

ZILOY is more than a care platform; it is a value-generating solution for employers, providers, and payers. Through early intervention, high engagement, and personalized care delivery, ZILOY improves behavioral health outcomes and supports reductions in absenteeism, presenteeism, and turnover, as well as decreases in behavioral health claims. It offers a scalable path forward for organizations investing in healthier workforces and more resilient communities.

Healthcare Triangle and QuantumNexis are committed to delivering high-growth, high-impact digital solutions that create long-term value for individuals, enterprises, and shareholders. ZILOY reflects this commitment and is fully commercially available by Q4 2025.

References:
[1] https://www.marketscreener.com/news/healthcare-triangle-s-subsidiary-quantumnexis-launches-ziloy-in-the-u-s-a-genai-powered-integrati-ce7c5edadf8ff321

Comments



Add a public comment...
No comments

No comments yet